Michael Eikmans

Dr. Michael Eikmans

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2003 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
KKKlaas Koop
Klaas Koop
MEMichael Eikmans
Michael Eikmans
HBHans Baelde
Hans Baelde
HKHiroshi Kawachi
Hiroshi Kawachi
EHEmile de Heer
Emile de Heer
JBJan A. Bruijn
Jan A. Bruijn
Proteinuria is a poorly understood feature of many acquired renal diseases. Recent studies concerning congenital nephrotic syndromes and findings in genetically modified mice have demonstrated that podocyte molecules make a pivotal contribution to the maintenance of the selective filtration barrier of the normal glomerulus. However, it is unclear what role podocyte molecules play in proteinuria of acquired renal diseases. This study investigated the mRNA and protein expression of several podocyte-associated molecules in acquired renal diseases. Forty-eight patients with various renal diseases were studied, including minimal change nephropathy, focal segmental glomerulosclerosis, IgA nephropathy, lupus nephritis, and diabetic nephropathy, together with 13 kidneys with normal glomerular function. Protein levels of nephrin, podocin, CD2-associated protein, and podocalyxin were investigated using quantitative immunohistochemical assays. Real-time PCR was used to determine the mRNA levels of nephrin, podocin, and podoplanin in microdissected glomeruli. The obtained molecular data were related to electron microscopic ultrastructural changes, in particular foot process width, and to clinical parameters. In most acquired renal diseases, except in IgA nephropathy, a marked reduction was observed at the protein levels of nephrin, podocin, and podocalyxin, whereas an increase of the glomerular mRNA levels of nephrin, podocin, and podoplanin was found, compared with controls. The mean width of the podocyte foot processes was inversely correlated with the protein levels of nephrin (r = −0.443, P < 0.05), whereas it was positively correlated with podoplanin mRNA levels (r = 0.468, P < 0.05) and proteinuria (r = 0.585, P = 0.001). In the diseases studied, the decrease of slit diaphragm proteins was related to the effacement of foot processes and coincided with a rise of the levels of the corresponding mRNA transcripts. This suggests that the alterations in the expression of podocyte-associated molecules represent a compensatory reaction of the podocyte that results from damage associated with proteinuria. E-mail: k.koop@lumc.nl

1 October 2015 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
EGE. M. Gielis
E. M. Gielis
KLK. J. Ledeganck
K. J. Ledeganck
BWBenedicte De Winter
Benedicte De Winter
JFJ. Del Favero
J. Del Favero
JBJ.-L. Bosmans
J.-L. Bosmans
MEMichael Eikmans
Michael Eikmans
After organ transplantation, donor-derived cell-free DNA (ddcfDNA) can be detected in the recipient's blood and urine. Different ddcfDNA quantification techniques have been investigated but a major breakthrough was made with the introduction of digital droplet PCR and massive parallel sequencing creating the opportunity to increase the understanding of ddcfDNA kinetics after transplantation. The observations of increased levels of ddcfDNA during acute rejection and even weeks to months before histologic features of graft rejection point to a possible role of ddcfDNA as an early, noninvasive rejection marker. In this review, we summarize published research on ddcfDNA in the transplantation field thereby elaborating on its clinical utility.

1 April 2004 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
HBHans Baelde
Hans Baelde
MEMichael Eikmans
Michael Eikmans
PDPeter Doran
Peter Doran
DLDavid W.P. Lappin
David W.P. Lappin
EHEmile de Heer
Emile de Heer
JBJan A. Bruijn
Jan A. Bruijn

1 October 2010 in The Journal of Immunology
Verified
Journal Article
Closed access
TTTamara Tilburgs
Tamara Tilburgs
DSDorrith Schonkeren
Dorrith Schonkeren
MEMichael Eikmans
Michael Eikmans
NNNicole M Nagtzaam
Nicole M Nagtzaam
GDGert Datema
Gert Datema
FCFrans H Claas
Frans H Claas
During pregnancy, maternal lymphocytes at the fetal–maternal interface play a key role in the immune acceptance of the allogeneic fetus. Recently, CD4+CD25bright regulatory T cells have been shown to be concentrated in decidual tissue, where they are able to suppress fetus-specific and nonspecific immune responses. Decidual CD8+ T cells are the main candidates to recognize and respond to fetal HLA-C at the fetal–maternal interface, but data on the characteristics of these cells are limited. In this study we examined the decidual and peripheral CD8+ T cell pool for CD45RA, CCR7, CD28, and CD27 expression, using nine-color flow cytometry. Our data demonstrate that decidual CD8+ T cells mainly consist of differentiated CD45RA−CCR7− effector-memory (EM) cells, whereas unprimed CD45RA+CCR7+ naive cells are almost absent. Compared with peripheral blood EM CD8+ T cells, the decidual EM CD8+ T cells display a significantly reduced expression of perforin and granzyme B, which was confirmed by immunohistochemistry of decidual tissue sections. Interestingly, quantitative PCR analysis demonstrates an increased perforin and granzyme B mRNA content in decidual EM CD8+ T cells in comparison with peripheral blood EM CD8+ T cells. The presence of high levels of perforin and granzyme B mRNA in decidual EM T cells suggests that decidual CD8+ T cells pursue alternative means of EM cell differentiation that may include a blockade of perforin and granzyme B mRNA translation into functional perforin and granzyme B proteins. Regulation of decidual CD8+ T cell differentiation may play a crucial role in maternal immune tolerance to the allogeneic fetus.

1 April 2007 in Kidney International
Verified
Journal Article
Closed access
PDF file
HBHans Baelde
Hans Baelde
MEMichael Eikmans
Michael Eikmans
DLD.W.P. Lappin
D.W.P. Lappin
PDPeter Doran
Peter Doran
DHD. Hohenadel
D. Hohenadel
JBJ.-A. Bruijn
J.-A. Bruijn

23 June 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JKJuliette Krop
Juliette Krop
SHSebastiaan Heidt
Sebastiaan Heidt
FCFrans H. J. Claas
Frans H. J. Claas
MEMichael Eikmans
Michael Eikmans
In pregnancy, the semi-allogeneic fetus needs to be tolerated by the mother's immune system. Regulatory T cells (Tregs) play a prominent role in this process. Novel technologies allow for in-depth phenotyping of previously unidentified immune cell subsets, which has resulted in the appreciation of a vast heterogeneity of Treg subsets. Similar to other immunological events, there appears to be great diversity within the Treg population during pregnancy, both at the maternal-fetal interface as in the peripheral blood. Different Treg subsets have distinct phenotypes and various ways of functioning. Furthermore, the frequency of individual Treg subsets varies throughout gestation and is altered in aberrant pregnancies. This suggests that distinct Treg subsets play a role at different time points of gestation and that their role in maintaining healthy pregnancy is crucial, as reflected for instance by their reduced frequency in women with recurrent pregnancy loss. Since pregnancy is essential for the existence of mankind, multiple immune regulatory mechanisms and cell types are likely at play to assure successful pregnancy. Therefore, it is important to understand the complete microenvironment of the decidua, preferably in the context of the whole immune cell repertoire of the pregnant woman. So far, most studies have focused on a single mechanism or cell type, which often is the FoxP3 positive regulatory T cell when studying immune regulation. In this review, we instead focus on the contribution of FoxP3 negative Treg subsets to the decidual microenvironment and their possible role in pregnancy complications. Their phenotype, function, and effect in pregnancy are discussed.